Newton, MA, United States of America

Andrey Peresypkin

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrey Peresypkin. Retrieved from https://idiyas.com/inventor/andrey-peresypkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrey Peresypkin

Introduction

Andrey Peresypkin is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cystic fibrosis. His work has led to advancements that could improve the lives of many patients suffering from this condition.

Latest Patents

Andrey holds 1 patent for his invention titled "Crystalline forms of CFTR modulators." This patent discloses crystalline forms of salts of Compound I, along with pharmaceutical compositions that comprise these salts. Additionally, it outlines methods for treating cystic fibrosis using these compositions and methods for their production.

Career Highlights

Andrey is currently employed at Vertex Pharmaceuticals, Inc., a leading company in the biotechnology sector. His role at Vertex allows him to work on innovative solutions that address critical health issues, particularly in the realm of rare diseases.

Collaborations

Throughout his career, Andrey has collaborated with talented individuals such as Satish Kumar Iyemperumal and Yi Shi. These collaborations have fostered an environment of innovation and creativity, contributing to the development of groundbreaking pharmaceutical solutions.

Conclusion

Andrey Peresypkin's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the treatment of cystic fibrosis, highlight the importance of research and development in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…